Redwood City, CA, May 7, 2025 – Osteoboost Health, Inc today announced the nationwide availability of Osteoboost, the first and only FDA-cleared prescription medical device for low bone density. Osteoboost represents a novel, protective and preventative approach to bone health at a time when tens of millions are left without…
Read more
REDWOOD CITY, CA (July 2, 2024) – Bone Health Technologies (BHT), a leading medtech innovator developing breakthrough noninvasive and drug-free solutions for low bone density, today announced the company has been awarded a fifth patent for Osteoboost—the first and only FDA-cleared prescription medical device to treat osteopenia. The patent, US…
Read more
This post first appeared on Femtech World We are seeing a societal sea change in recognising the importance of and attitudes towards the menopause experience, says Laura Yecies. Long in the backwater and ignored, we increasingly recognise the significant impact menopausal symptoms have on women’s quality of life and the considerable health consequences the…
Read more
